Therapeutic effectiveness of Probiotic in GI Infectio
Phase 2
- Conditions
- Helicobacter pylori Infection.Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
- Registration Number
- IRCT2015071523219N1
- Lead Sponsor
- Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
inclusion criteria:
Age >18 Years; Dyspepsia; confirmed H.Pylori
Exclusion criteria :
acute and chronic GI disease; Renal failure; Neurological disease; use of Antibiotic or probiotic within previous 30 days
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method H.pylori Infection. Timepoint: Before and 4 weeks after end of treatment. Method of measurement: Fecal H.pylori or Urea Breathing Test.
- Secondary Outcome Measures
Name Time Method Allergia; Diarrea; Nausea; Vometing; Bloating. Timepoint: Before and 4 weeks after end of treatment. Method of measurement: Hystory and Physical exam.